Digital Therapeutics Market Size, Share, Growth Analysis, By Offering(Software/platforms, Programs, Virtual reality/games), By Revenue Model(Subscription-based model, One-time Purchase/Annual Licensing Model, and Outcome /value-based model), By Application(Treatment/care-related applications, and Preventive Applications), By Distribution Channel (B2B sales channel), By Region - Industry Forecast 2024-2031

Global Digital Therapeutics Market size was valued at USD 3.44 billion in 2022 and is poised to grow from USD 4.01 billion in 2023 to USD 13.72 billion by 2031, at a CAGR of 16.61 % during the forecast period (2024-2031).

Digital therapeutics consists of software and devices that digitally maintain evidence-based therapeutic interventions. It helps medical providers to efficiently prevent and manage diseases. The software and devices help in treating different types of diseases like mental health, diabetes, respiratory diseases, and cardiovascular diseases. The demand for these products is increasing immensely because of the growing incidences of chronic diseases like diabetes, mental illness, cancer, and heart failure. These factors are increasing the adoption of therapeutics for managing and treating different chronic disorders among patients. Furthermore, the popularity of these products is also increasing in the pharmaceutical sector, which is also positively influencing the market growth. The market leaders are also emphasizing research and development activities to produce advanced therapies for treating different diseases, which is accelerating the production of these products. These factors are leading to the expansion of the digital therapeutics market.

US Digital Therapeutics Market is poised to grow at a sustainable CAGR for the next forecast year.